Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets
Authors:
- Simone Treiger SredniSSSimone Treiger Sredni
- Maria de Fátima BonaldoMBMaria de Fátima Bonaldo
- Fabrício Falconi CostaFCFabrício Falconi Costa
- Jared Marshall BischofJBJared Marshall Bischof
- Marcelo Bento SoaresMSMarcelo Bento Soares
- 10 December 2009
- journal article
- research article
- Published by Springer Nature in Child's Nervous System
- Vol. 26 (3) , 279-283
Abstract
The aim of this study is to search for new therapeutic targets for atypical teratoid–rhabdoid tumors (ATRT).Keywords
This publication has 20 references indexed in Scilit:
- Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivoInternational Journal of Oncology, 2009
- Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid TumorJournal of Clinical Oncology, 2009
- The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in MicePLOS ONE, 2008
- p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesisMolecular Cancer Therapeutics, 2008
- Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferationThe EMBO Journal, 2007
- Molecular therapy in the microRNA eraThe Pharmacogenomics Journal, 2006
- How to decrease p27Kip1 levels during tumor developmentCancer Cell, 2006
- Standard-Risk Medulloblastoma Treated by Adjuvant Chemotherapy Followed by Reduced-Dose Craniospinal Radiation Therapy: A French Society of Pediatric Oncology StudyJournal of Clinical Oncology, 2005
- MicroRNAsCell, 2004
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001